The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy

OBJECTIVES: To explore clinically relevant differences in severity of vulvar and vaginal atrophy (VVA) in postmenopausal women treated with ospemifene compared with placebo. METHODS: Analysis of two multicenter, randomized, double-blind, 12-week phase-III studies in postmenopausal women (40–80 years...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Climacteric
Glavni autori: Nappi, R. E., Panay, N., Bruyniks, N., Castelo-Branco, C., De Villiers, T. J., Simon, J. A.
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4438339/
https://ncbi.nlm.nih.gov/pubmed/25335119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/13697137.2014.975199
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items